Sort
10,766 grants matching “checkpoint inhibitor”
Regulation of immune responses by inhibitory receptors
$353,073Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Project 1: Siglec15 as a new target for lung cancer immunotherapy
$353,055Lieping Chen · Yale University · P50 · FY2022 · CA
Identifying and targeting a novel mechanism of chemotherapy-induced immunotherapeutic resistance in non-small cell lung cancer
$353,044Kavitha Yaddanapudi · University Of Louisville · R01 · FY2025 · CA
Protein Kinase Signaling and Cell Cycle Control
$352,978Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2008 · ES
Checkpoint Kinase Chk1 in Cancer Biology and Therapy
$352,935Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2011 · CA
Role of Nuclear Pore-Regulated Mechanisms in Prostate Cancer Aggressiveness
$352,912Veronica Rodriguez-Bravo · Mayo Clinic Rochester · R01 · FY2022 · CA
Project 1 - Integrating targeted and immune therapies for BRAF mutant colorectal cancer
$352,875Arlene H Sharpe · Dana-Farber Cancer Inst · P50 · FY2019 · CA
Monocyte promotion of therapy resistance by immune and non-immune mechanisms
$352,801Yi Lin · Mayo Clinic Rochester · R01 · FY2019 · CA
Mechanism of double-negative T cells in antitumor immunity to breast cancer
$352,757Hui Zhang · University Of Louisville · R01 · FY2025 · CA
Functional analysis of BRCA1 in DNA damage response and tumor suppression
$352,750Xiaochun Yu · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
Functional analysis of BRCA1 in DNA damage response and tumor suppression
$352,750Xiaochun Yu · Beckman Research Institute/City Of Hope · R01 · FY2016 · CA
Functional analysis of BRCA1 in DNA damage response and tumor suppression
$352,750Xiaochun Yu · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
Functional analysis of BRCA1 in DNA damage response and tumor suppression
$352,750Xiaochun Yu · Beckman Research Institute/City Of Hope · R01 · FY2015 · CA
HPV AND ANTIGEN PRESENTING CELLS
$352,688W Martin Kast · University Of Southern California · R01 · FY2017 · CA
Regulation of repetitive elements in cancer by P53 and epigenetic mechanisms
$352,665Katherine B Chiappinelli · George Washington University · R37 · FY2024 · CA
Protein Kinase Signaling and Cell Cycle Control
$352,653Michael B Yaffe · Massachusetts Institute Of Technology · R01 · FY2009 · ES
Deubiquitinases in Cell Cycle Control
$352,617Michael James Emanuele · Univ Of North Carolina Chapel Hill · R01 · FY2023 · GM
Deubiquitinases in Cell Cycle Control
$352,617Michael James Emanuele · Univ Of North Carolina Chapel Hill · R01 · FY2022 · GM
Core B: Clinical Core
$352,588Arthur Y Kim · Massachusetts General Hospital · U19 · FY2025 · AI
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
$352,374Tracy L McGaha · University Health Network · R01 · FY2024 · CA
Impact of concomitant chemotherapy on HIV resistance to cART and reservoir size
$352,332Alonso Heredia · University Of Maryland Baltimore · R01 · FY2019 · CA
Oncolytic Adenovirus Armed with SA-4-1BBL Immune Checkpoint Stimulator for Lung Cancer Immunotherapy
$352,332Jorge G Gomez-Gutierrez · University Of Missouri-Columbia · R21 · FY2021 · CA
Regulation of the Development of Trypanosoma brucei
$352,300Ching Chung Wang · University Of California, San Francisco · R01 · FY2008 · AI
Dual function of HSP70 in cytoprotection of tumor cells and generation of permissive microenvironment
$352,275Hasan Korkaya · Wayne State University · R01 · FY2025 · CA
A novel therapeutic strategy to eradicate breast cancer through Hsp90 inhibition and reduced immune tolerance
$352,275Ahmed Chadli · Augusta University · R01 · FY2025 · CA